Valirx (VAL)

0.41p
   
  • Change Today:
      0.025p
  • 52 Week High: 0.86p
  • 52 Week Low: 0.34p
  • Currency: UK Pounds
  • Shares Issued: 1,259.56m
  • Volume: 1,771,931
  • Market Cap: £5.16m
  • RiskGrade: 409
  • Beta: 0.40

Valirx Overview

Valirx is in the pharmaceuticals & biotechnology sector and is currently trading at 0.41p per share. In the last year Valirx's share price has ranged from 0.34p to 0.86p.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -238.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 11.3 n/a
Pr/Book 1.2  
Latest F'cast
Revenue 156.8% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Valirx Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 0.04 (1.29) (4.11)p n/a n/a n/a n/a 0.0%
31-Dec-08 0.03 (1.89) (4.13)p n/a n/a n/a n/a 0.0%
31-Dec-09 0.01 (1.26) (0.09)p n/a n/a n/a n/a 0.0%
31-Dec-10 0.18 0.25 0.07p 3.4 n/a n/a n/a 0.0%
31-Dec-11 0.46 (1.07) (0.10)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Valirx Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Valirx Company Announcements

New US Patent Grant 15-May-2012 07:00 RNS
Final Results 27-Apr-2012 07:00 RNS
Director/PDMR Shareholding 02-Apr-2012 12:17 RNS

Latest Valirx Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.41p
Change Today 0.025p
% Change 6.49 %
52 Week High 0.86p
52 Week Low 0.34p
Volume 1,771,931
Shares Issued 1,259.56m
Market Cap £5.16m
Beta 0.40
RiskGrade 409

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.18% below the market average8.18% below the market average8.18% below the market average8.18% below the market average8.18% below the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Price Trend
48.42% below the market average48.42% below the market average48.42% below the market average48.42% below the market average48.42% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average
Income Not Available
Growth
68.48% above the market average68.48% above the market average68.48% above the market average68.48% above the market average68.48% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average

Valirx Dividends

No dividends found

Trades for 25-May-2012

Time Volume / Share Price
16:23 100,000 @ 0.37p
12:18 287,660 @ 0.37p
10:36 836,001 @ 0.35p
10:26 50,000 @ 0.37p
09:14 498,270 @ 0.37p

Valirx Key Personnel

CFO Gerald Desler
CEO Satu Vainikka

Top of Page